Mohsen, Mona O. https://orcid.org/0000-0003-3510-9148
Heath, Matthew D.
Cabral-Miranda, Gustavo
Lipp, Cyrill
Zeltins, Andris
Sande, Marcos
Stein, Jens V.
Riether, Carsten
Roesti, Elisa
Zha, Lisha
Engeroff, Paul
El-Turabi, Aadil
Kundig, Thomas M.
Vogel, Monique
Skinner, Murray A.
Speiser, Daniel E.
Knuth, Alexander
Kramer, Matthias F.
Bachmann, Martin F.
Article History
Received: 13 November 2018
Accepted: 2 April 2019
First Online: 26 April 2019
Change Date: 23 May 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the author reported an author’s family name has been misspelled. Paul Engroff should be replace Paul Engeroff.Furthermore, there are two mistake in two affiliations: 9) Department of dermatology, University of Zurich, Bern, Switzerland and 10) Department of Oncology, University of Lausanne, Bern,Switzerland should be replace with 9) Department of dermatology, University of Zurich, Zurich, Switzerland.10) Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Ethics approval
: All procedures on animals were conducted at University of Bern in accordance with the Swiss Animals Act (455.109.1) (September 2008, 5th) University of Bern.
: Not applicable.
: The authors declare that they have no competing interests. Martin Bachmann and Mona Mohsen own shares of DeepVax GmbH involved in developing virus-like particles based vaccines for cancer, other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.